May 1, 2026 · 1h 20m · allin
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions
In this episode of the All-In Podcast, hosts Jason Calacanis, Chamath Palihapitiya, David Sacks, and David Friedberg analyze OpenAI's performance targets, Big Tech's unprecedented AI CapEx surge, the legal showdown between Elon Musk and Sam Altman, and breakthrough weight-loss peptides alongside firsthand insights from a Supreme Court visit. The hosts combine rigorous technology, business, and legal analysis with lighthearted host banter and personal anecdotes.
How this conversation actually went
Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 97.3% of the talking time here. How this is scored →
speaking balance: gold is the hosts, purple is the guest (3 minute bins)
Chamath forcefully mocks Jason for staying in a small, messy single room in Atlanta while bragging about spending thirty thousand dollars on courtside basketball tickets.
Hardest push from the hosts ▶ 11:38 Chamath Interrupts to Correct Jason on Power vs ComputeChamath explicitly interrupts and shuts down Jason's summary, insisting that power infrastructure rather than raw compute availability is the true bottleneck.
Biggest teaching moment ▶ 58:55 Friedberg Teaches Co-Hosts on Retatrutide BiochemistryFriedberg provides an authoritative technical explanation of how glucagon receptor binding differentiates Retatrutide from Terzepatide by sparing muscle mass.
The host holds their own ▶ 48:40 Sacks Lays Out Definitive Macro AI Bull ThesisSacks counters doomer narratives by methodically demonstrating how AI infrastructure investment accounts for seventy-five percent of national GDP growth.
the scores for every segment, with the reasoning behind each
| Chapter | Topic | The hosts as informed peer | Guest teaching | Guest disagreement | The hosts pushing back | Why |
|---|---|---|---|---|---|---|
| Banter: Miss Thing Podcast's Gay Name or Straight Name | 1 | 0 | 2 | 0 | Jason plays comedy clips from the Miss Thing Podcast poking fun at David Friedberg and Chamath. The exchange is purely humorous banter about name stereotypes and poker nights without formal expert debate. | |
| Show Title Sequence & Introduction | 3 | 0 | 0 | 0 | Jason introduces the main show topics including OpenAI missing user and revenue targets and Wall Street Journal report details. He summarizes company financials and internal tension between CFO Sarah Friar and Sam Altman. | |
| Sacks on GPT 5.5 vs Claude and Compute Gating | 6 | 0 | 0 | 0 | Sacks presents a contrarian take on OpenAI, arguing that product releases like GPT 5.5 and new base model Spud are shifting developer mojo back from Anthropic's Claude. He details Anthropic's compute gating issues with Opus 4.7. | |
| Chamath on Grid Infrastructure and Power Limits | 7 | 0 | 0 | 1 | Chamath argues that AI model growth is bottlenecked primarily by grid power infrastructure rather than raw compute demand. He corrects Jason's summary, emphasizing supply chain delays in grid transformers and red tape. | |
| Friedberg on Market Dynamics and Model Pruning | 8 | 0 | 0 | 0 | Friedberg applies BCG's Rule of Three to consumer and enterprise AI market shares. He highlights an MIT research paper demonstrating a 90 percent reduction in neural network size through model pruning to yield 10x inference efficiency per energy unit. | |
| Sacks on Google's Market Gains and GPT-5.5 Cyber | 6 | 0 | 0 | 0 | Sacks highlights OpenAI's competitive gains in consumer search and coding with Codex. He cites testing by the AI Security Institute showing GPT 5.5 Cyber passing multi-step cyber attack simulations. | |
| Cybersecurity Upgrades and Machine-vs-Machine Warfare | 7 | 0 | 0 | 1 | Sacks explains how AI tools discover existing code vulnerabilities rather than create them, leading to a one-time upgrade cycle. Chamath extends this by describing machine-written code rewriting legacy software. | |
| Banter: Hotel Rooms, Courtside Seats, and Private Jets | 1 | 0 | 4 | 3 | Chamath roasts Jason for staying in a single messy hotel room in Atlanta while spending thirty thousand dollars on courtside Knicks seats. Sacks adds a story about consuming twelve thousand dollars worth of vintage Pappy Van Winkle on his private jet. | |
| Elon Musk vs. Sam Altman Trial and Brockman's Diary | 4 | 0 | 1 | 0 | Jason discusses the Elon Musk vs. Sam Altman trial, highlighting Greg Brockman's journal entries and playing a clip from The Wire about taking notes on a criminal conspiracy. Chamath notes Polymarket odds remaining steady. | |
| The Therapy Industrial Complex and Rumination | 4 | 0 | 2 | 1 | Jason critiques the modern therapy industry for encouraging unproductive rumination, while Chamath clarifies the utility of addressing specific psychological trauma versus endless self-reflection. Sacks details OpenAI's historical equity offer to Musk. | |
| All-In Summit Announcement and Host Banter | 7 | 0 | 0 | 0 | Following Summit event banter, Jason breaks down seven hundred twenty-five billion in tech CapEx guidance. Chamath provides deep financial analysis on hyperscaler leverage and nuclear purchase agreements like Three Mile Island at double spot rates. | |
| David Sacks' Macro Bull Case for AI and Economic Growth | 8 | 0 | 1 | 0 | Sacks refutes comparisons to the 2000 dark fiber bubble, presenting a macro thesis that AI CapEx and token generation account for seventy-five percent of recent GDP growth and drive broad productivity gains. | |
| Vibe Coding Risks, AI Agent Disasters, and the Gartner Hype Cycle | 6 | 0 | 0 | 0 | Jason shares an incident where Claude deleted a production database at Pocket OS, quoting a comedic scene from Silicon Valley. Sacks quotes Aaron Levie on why agentic coding still requires human oversight and accountability. | |
| Eli Lilly's Retatrutide Trial and the Breakthrough Peptide Craze | 9 | 0 | 0 | 0 | Friedberg delivers an in-depth breakdown of Eli Lilly's Retatrutide Phase 3 clinical trial results, detailing how its triple agonist mechanism targeting GLP-1, GIP, and glucagon receptors promotes selective fat burning over muscle loss. | |
| Ro Endorsement Banter and Chamath's Sparks Anecdote | 1 | 0 | 3 | 2 | The hosts joke about Jason's sponsorship with telehealth provider Ro, leading to Chamath sharing a personal story about scheduling the use of Ro Sparks with his wife Nat. | |
| David Friedberg's Supreme Court Visit & The Monsanto Case | 9 | 0 | 0 | 0 | Friedberg details his experience attending oral arguments at the Supreme Court regarding the Monsanto Roundup case, explaining the conflict between federal preemption under FIFRA and state-level failure-to-warn statutes post-Chevron. | |
| Supreme Court Deliberation Mechanics and Institutional Reputation | 6 | 0 | 0 | 0 | Chamath recounts a story from Senator Ted Cruz regarding Chief Justice William Rehnquist and internal Supreme Court conference procedures. Sacks provides recent Gallup favorability statistics for the court. | |
| Debate on Court-Packing and Monetization Proposals | 3 | 0 | 2 | 1 | Sacks quotes James Carville on potential Democratic plans for court-packing, while Jason satirically suggests monetizing Supreme Court attendance with courtside seats and auctions. |